Ongoing evidence reveals that brain and possibly peripheral insulin resistance and concomitant hyperglycemia may be key metabolic dysfunctions contributing to Alzheimer’s disease [8,11,12]. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.